Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Vaccitech Q2 EPS $(0.62) Misses $(0.55) Estimate, Sales $334.00K Miss $600.00K Estimate

Author: Benzinga Newsdesk | August 10, 2023 08:13am
Vaccitech (NASDAQ:VACC) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.55) by 12.73 percent. This is a 251.22 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $334.00 thousand which missed the analyst consensus estimate of $600.00 thousand by 44.33 percent. This is a 98.04 percent decrease over sales of $17.06 million the same period last year.

Posted In: VACC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist